glp-1 pharmacokinetics receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 Analogues in the Neurobiology

Endocrinology 151 , 30493060 (2010)

New real-world data is shifting the paradigm in how we understand colon cancer progression

National healthcare systems should comprehensively assess the implementation of recommendations and create incentives for effective programmes

It feels louder

Patients should also seek medical advice if muscle symptoms are accompanied by systemic features such as fever, unexplained weight loss beyond what is expected from GLP-1 therapy, rash, joint swelling, or other concerning signs that might suggest inflammatory or autoimmune conditions

However, patients with PBH still have higher peak glucose levels after GLP-1r antagonist treatment compared to asymptomatic patients